SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 35 filers reported holding SPRING BK PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $952,000 | -6.8% | 276,656 | 0.0% | 0.16% | +34.4% |
| Q2 2019 | $1,021,000 | -64.8% | 276,656 | 0.0% | 0.12% | -65.0% |
| Q1 2019 | $2,902,000 | +11.0% | 276,656 | +9.9% | 0.35% | -1.7% |
| Q4 2018 | $2,615,000 | -25.6% | 251,656 | -13.7% | 0.36% | -4.8% |
| Q3 2018 | $3,514,000 | +125.3% | 291,656 | +121.5% | 0.37% | +114.4% |
| Q2 2018 | $1,560,000 | -23.0% | 131,656 | 0.0% | 0.17% | -21.6% |
| Q1 2018 | $2,025,000 | +22.1% | 131,656 | +6.7% | 0.22% | +7.2% |
| Q4 2017 | $1,658,000 | -20.2% | 123,383 | 0.0% | 0.21% | -22.8% |
| Q3 2017 | $2,078,000 | +36.4% | 123,383 | +9.7% | 0.27% | +60.5% |
| Q2 2017 | $1,523,000 | – | 112,500 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARSONS CAPITAL MANAGEMENT INC/RI | 195,165 | $1,559,000 | 0.21% |
| DAFNA Capital Management LLC | 27,412 | $219,000 | 0.19% |
| Verity & Verity, LLC | 12,385 | $99,000 | 0.03% |
| Baker Brothers Advisors | 219,298 | $1,752,000 | 0.02% |
| Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
| Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 97,286 | $777,000 | 0.01% |
| BRYN MAWR TRUST Co | 14,000 | $112,000 | 0.01% |
| BlackRock Investment Management, LLC | 163 | $1,000 | 0.00% |
| MORGAN STANLEY | 12,500 | $100,000 | 0.00% |